BAO PHARMA-B 02659
11.3502.99%( -0.350 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
BAO PHARMA-B (02659) Major Shareholders - Stakes, Shares Held and Changes - cibo
| Shareholder | |||
|---|---|---|---|
| 刘彦君Executive Director | 16.98% | 26.21M | |
| 王征Executive Director | 16.98% | 26.21M | |
| 譚靖偉 | 16.92% | 26.11M | |
| Fangyuan Capital (Hong Kong) Limited | 14.04% | 21.66M | |
| 鄭娟 | 14.04% | 21.66M | |
| 上海生物醫藥產業股權投資基金管理有限公司 | 5.75% | 8.87M | |
| Li Jiaqi | 5.39% | 8.32M | |
| Qian Jincheng | 5.39% | 8.32M | |
| 晟德大藥廠股份有限公司 | 5.17% | 7.98M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of BAO PHARMA-B (02659) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.
